173 related articles for article (PubMed ID: 26416339)
21. Episodic and continuous breathlessness: a new categorization of breathlessness.
Simon ST; Higginson IJ; Benalia H; Gysels M; Murtagh FE; Spicer J; Bausewein C
J Pain Symptom Manage; 2013 Jun; 45(6):1019-29. PubMed ID: 23017608
[TBL] [Abstract][Full Text] [Related]
22. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
[TBL] [Abstract][Full Text] [Related]
23. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.
Currow DC; Smith J; Davidson PM; Newton PJ; Agar MR; Abernethy AP
J Pain Symptom Manage; 2010 Apr; 39(4):680-90. PubMed ID: 20413056
[TBL] [Abstract][Full Text] [Related]
24. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, Clinical Characteristics, and Management of Episodic Dyspnea in Advanced Lung Cancer Outpatients: A Multicenter Nationwide Study-The INSPIRA-DOS Study.
Julià-Torras J; Almeida Felipe JM; Gándara Del Castillo Á; González-Barboteo J; Forero D; Alegre S; Cuervo-Pinna MÁ; Serna J; Muñoz-Unceta N; Alonso-Babarro A; Miró Catalina Q; Moreno-Alonso D; Porta-Sales J
J Palliat Med; 2022 Aug; 25(8):1197-1207. PubMed ID: 35196465
[No Abstract] [Full Text] [Related]
26. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
27. Physiological and functional failure in chronic obstructive pulmonary disease, congestive heart failure and cancer: a debilitating intersection of sarcopenia, cachexia and breathlessness.
Dudgeon D; Baracos VE
Curr Opin Support Palliat Care; 2016 Sep; 10(3):236-41. PubMed ID: 27380222
[TBL] [Abstract][Full Text] [Related]
28. [Characteristics of patients with breathlessness - results of the german hospice and palliative care evaluation].
Simon ST; Altfelder N; Alt-Epping B; Bausewein C; Weingärtner V; Voltz R; Ostgathe C; Radbruch L; Lindena G; Nauck F
Dtsch Med Wochenschr; 2016 May; 141(10):e87-95. PubMed ID: 27176070
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
[TBL] [Abstract][Full Text] [Related]
30. Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management.
Mercadante S
Drugs; 2018 Apr; 78(5):543-547. PubMed ID: 29470801
[TBL] [Abstract][Full Text] [Related]
31. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial.
Higginson IJ; Bausewein C; Reilly CC; Gao W; Gysels M; Dzingina M; McCrone P; Booth S; Jolley CJ; Moxham J
Lancet Respir Med; 2014 Dec; 2(12):979-87. PubMed ID: 25465642
[TBL] [Abstract][Full Text] [Related]
32. Opioids for management of episodic breathlessness or dyspnea in patients with advanced disease.
Cabezón-Gutiérrez L; Khosravi-Shahi P; Custodio-Cabello S; Muñiz-González F; Cano-Aguirre Mdel P; Alonso-Viteri S
Support Care Cancer; 2016 Sep; 24(9):4045-55. PubMed ID: 27334130
[TBL] [Abstract][Full Text] [Related]
33. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
34. Outcome measurement of refractory breathlessness: endpoints and important differences.
Ekström M; Currow DC; Johnson MJ
Curr Opin Support Palliat Care; 2015 Sep; 9(3):238-43. PubMed ID: 26203849
[TBL] [Abstract][Full Text] [Related]
35. What can we learn about breathlessness from population-based and administrative health data?
Ekström M
Curr Opin Support Palliat Care; 2016 Sep; 10(3):223-7. PubMed ID: 27489182
[TBL] [Abstract][Full Text] [Related]
36. Breathlessness and crises in the context of advanced illness: A comparison between COPD and lung cancer patients.
Dunger C; Higginson IJ; Gysels M; Booth S; Simon ST; Bausewein C
Palliat Support Care; 2015 Apr; 13(2):229-37. PubMed ID: 24524686
[TBL] [Abstract][Full Text] [Related]
37. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness.
Gysels M; Higginson IJ
J Pain Symptom Manage; 2008 Nov; 36(5):451-60. PubMed ID: 18495412
[TBL] [Abstract][Full Text] [Related]
38. Acceptability and preferences of six different routes of drug application for acute breathlessness: a comparison study between the United Kingdom and Germany.
Simon ST; Niemand AM; Benalia H; Voltz R; Higginson IJ; Bausewein C
J Palliat Med; 2012 Dec; 15(12):1374-81. PubMed ID: 23094954
[TBL] [Abstract][Full Text] [Related]
39. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD.
Gifford AH; Mahler DA; Waterman LA; Ward J; Kraemer WJ; Kupchak BR; Baird JC
COPD; 2011 Jun; 8(3):160-6. PubMed ID: 21513438
[TBL] [Abstract][Full Text] [Related]
40. Intranasal Fentanyl Versus Placebo for Treatment of Episodic Breathlessness in Hospice Patients With Advanced Nonmalignant Diseases.
Iupati S; Bridge R; Allan S; Hewitt D
J Pain Symptom Manage; 2021 May; 61(5):1035-1041. PubMed ID: 33186729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
